Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Josephine Li, M.D.

Concepts (64)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Metformin420238351.360 Why?
Diabetes Mellitus, Type 272023117250.770 Why?
Sulfonylurea Compounds220212040.730 Why?
Hypoglycemic Agents6202328720.620 Why?
Prediabetic State120234990.620 Why?
Organic Anion Transporters120151000.480 Why?
Cholesterol, LDL2201523560.450 Why?
Iodine120152860.440 Why?
Glipizide22023470.410 Why?
Iodine Radioisotopes1201510320.400 Why?
Interleukins320117910.400 Why?
Hepatitis C, Chronic3201110310.310 Why?
Blood Glucose5202362560.250 Why?
Pharmacogenetics220206750.250 Why?
Thyroid Neoplasms1201522820.210 Why?
Genome-Wide Association Study52023122610.200 Why?
Glucose2202343970.190 Why?
Genetic Variation4202365440.190 Why?
Genotype62023129510.180 Why?
Polymorphism, Single Nucleotide62023155190.180 Why?
Thyroiditis12020850.180 Why?
Genetic Predisposition to Disease22020174460.170 Why?
Diet1201579390.150 Why?
Interferons320117060.110 Why?
Hypoglycemia120198610.110 Why?
Cardiovascular Agents120168500.090 Why?
Thyroidectomy120158790.090 Why?
Heterozygote1201528040.080 Why?
Ribavirin120103950.080 Why?
Treatment Outcome42020631140.070 Why?
Humans1520237443430.070 Why?
Interferon-alpha120108950.070 Why?
Fatty Liver120117270.060 Why?
Insulin1201965800.060 Why?
Polyethylene Glycols1201011820.060 Why?
Alleles1201569330.060 Why?
Combined Modality Therapy1201586420.060 Why?
Survival Analysis12015102520.050 Why?
C-Peptide120234190.050 Why?
Antiviral Agents2201129870.050 Why?
Genetic Association Studies1201027030.050 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors1201532550.040 Why?
Registries1201580890.040 Why?
Likelihood Functions1202110050.040 Why?
Practice Guidelines as Topic1201572790.040 Why?
Treatment Failure1202326180.040 Why?
Male620203501180.040 Why?
Female620203801940.030 Why?
Middle Aged520192133830.030 Why?
Myocardial Infarction12015117270.030 Why?
Cardiovascular Diseases12016151650.020 Why?
Mutation, Missense1201925640.020 Why?
Adult520232140550.020 Why?
Risk Factors12015722900.020 Why?
Ultrasonography1202059850.020 Why?
Lipoproteins120118780.020 Why?
Diagnosis, Differential12020129590.020 Why?
Lipid Metabolism1201118890.010 Why?
Hepacivirus1201013790.010 Why?
Viral Load1201032990.010 Why?
Recombinant Proteins1201066220.010 Why?
Drug Therapy, Combination1201064890.010 Why?
Adolescent12023857810.010 Why?
Cohort Studies12011405610.000 Why?
Li's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (64)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.